Mankind Pharma Limited develops, manufactures and markets pharmaceutical formulations and consumer healthcare products in India and international markets. Its pharmaceutical portfolio covers therapeutic areas including anti-infectives, cardiovascular care, diabetes, gastroenterology, gynaecology, urology, dermatology, respiratory care and pain management. The company also offers consumer healthcare products under brands including Manforce, Prega News and other established names. Incorporated in 1991, Mankind Pharma is based in New Delhi, India.
Track the latest Mankind Pharma Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.
You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.
Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.
This page brings together the most important technical indicators for Mankind Pharma Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.
Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Mankind Pharma before making your own investment decisions.
Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.